174 related articles for article (PubMed ID: 18221103)
1. A practical approach to diagnosis and treatment of symptomatic thromboembolic events in children with acute lymphoblastic leukemia: recommendations of the "Coagulation Defects" AIEOP Working Group.
Giordano P; Del Vecchio GC; Saracco P; Zecca M; Molinari AC; De Mattia D;
Recent Pat Cardiovasc Drug Discov; 2007 Jan; 2(1):53-62. PubMed ID: 18221103
[TBL] [Abstract][Full Text] [Related]
2. THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents.
Greiner J; Schrappe M; Claviez A; Zimmermann M; Niemeyer C; Kolb R; Eberl W; Berthold F; Bergsträsser E; Gnekow A; Lassay E; Vorwerk P; Lauten M; Sauerbrey A; Rischewski J; Beilken A; Henze G; Korte W; Möricke A;
Haematologica; 2019 Apr; 104(4):756-765. PubMed ID: 30262570
[TBL] [Abstract][Full Text] [Related]
3. TropicALL study: Thromboprophylaxis in Children treated for Acute Lymphoblastic Leukemia with Low-molecular-weight heparin: a multicenter randomized controlled trial.
Klaassen ILM; Lauw MN; van de Wetering MD; Biemond BJ; Middeldorp S; Abbink FCH; Bierings M; Te Loo DMMW; Pieters R; van der Sluis IM; Tissing WJE; Michel Zwaan C; Heleen van Ommen C
BMC Pediatr; 2017 May; 17(1):122. PubMed ID: 28486976
[TBL] [Abstract][Full Text] [Related]
4. A survey on thromboprophylaxis and coagulation assessment in children and young adults with acute lymphoblastic leukaemia (ALL) in the Nordic and Baltic countries: Different practices of assessment and management.
Andersson NG; Rathe M; Mølle I; Jarvis KB; Hoffmann M; Huurre A; Joelsson J; Albertsen BK; Lohi O; Långström S; Overgaard U; Saulyte Trakymiene S; Vepsäläinen K; Vogt H; Ranta S
Br J Haematol; 2022 Oct; 199(1):117-121. PubMed ID: 35922061
[TBL] [Abstract][Full Text] [Related]
5. Low-molecular-weight heparin in pediatric patients.
Sutor AH; Chan AK; Massicotte P
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():31-9. PubMed ID: 15085464
[TBL] [Abstract][Full Text] [Related]
6. Comparison of low-molecular-weight heparin and antithrombin versus antithrombin alone for the prevention of symptomatic venous thromboembolism in children with acute lymphoblastic leukemia.
Meister B; Kropshofer G; Klein-Franke A; Strasak AM; Hager J; Streif W
Pediatr Blood Cancer; 2008 Feb; 50(2):298-303. PubMed ID: 17443678
[TBL] [Abstract][Full Text] [Related]
7. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
8. Antithrombotic therapy in children: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Monagle P; Chan A; Massicotte P; Chalmers E; Michelson AD
Chest; 2004 Sep; 126(3 Suppl):645S-687S. PubMed ID: 15383489
[TBL] [Abstract][Full Text] [Related]
9. Low molecular weight heparin in children.
Albisetti M; Andrew M
Eur J Pediatr; 2002 Feb; 161(2):71-7. PubMed ID: 11954754
[TBL] [Abstract][Full Text] [Related]
10. A prospective cohort study determining the prevalence of thrombotic events in children with acute lymphoblastic leukemia and a central venous line who are treated with L-asparaginase: results of the Prophylactic Antithrombin Replacement in Kids with Acute Lymphoblastic Leukemia Treated with Asparaginase (PARKAA) Study.
Mitchell LG; Andrew M; Hanna K; Abshire T; Halton J; Anderson R; Cherrick I; Desai S; Mahoney D; McCuster P; Wu J; Dahl G; Chait P; de Veber G; Lee KJ; Mikulis D; Ginsberg J; Way C;
Cancer; 2003 Jan; 97(2):508-16. PubMed ID: 12518376
[TBL] [Abstract][Full Text] [Related]
11. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.
Santoro N; Colombini A; Silvestri D; Grassi M; Giordano P; Parasole R; Barisone E; Caruso R; Conter V; Valsecchi MG; Masera G; Rizzari C
J Pediatr Hematol Oncol; 2013 Jul; 35(5):348-55. PubMed ID: 23619106
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the outcomes associated with periprocedural anticoagulation management in children with acute lymphoblastic leukemia.
Avila ML; Macartney CA; Hitzler JK; Williams S; Kiss A; Brandão LR
J Pediatr; 2014 May; 164(5):1201-7. PubMed ID: 24582006
[TBL] [Abstract][Full Text] [Related]
13. Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols.
Bhatt MD; Parmar N; Fowler JA; Chan AKC; Athale UH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27483. PubMed ID: 30362248
[TBL] [Abstract][Full Text] [Related]
14. [Thrombophilia, thromboembolism and the use of the unfractionated and low-molecular-weight heparins].
Lobato-Mendizábal E; Majluf-Cruz A
Rev Invest Clin; 2000; 52(5):529-45. PubMed ID: 11195182
[TBL] [Abstract][Full Text] [Related]
15. Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for venous thromboembolism.
van Den Belt AG; Prins MH; Lensing AW; Castro AA; Clark OA; Atallah AN; Burihan E
Cochrane Database Syst Rev; 2000; (2):CD001100. PubMed ID: 10796593
[TBL] [Abstract][Full Text] [Related]
16. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A meta-analysis of randomized, controlled trials.
Gould MK; Dembitzer AD; Doyle RL; Hastie TJ; Garber AM
Ann Intern Med; 1999 May; 130(10):800-9. PubMed ID: 10366369
[TBL] [Abstract][Full Text] [Related]
17. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism.
van Der Heijden JF ; Hutten BA; Büller HR; Prins MH
Cochrane Database Syst Rev; 2000; (4):CD002001. PubMed ID: 11034739
[TBL] [Abstract][Full Text] [Related]
18. [Venous thrombosis--a diagnostic and therapeutic challenge].
Spengel FA; von Liebe S
Radiologe; 1998 Jul; 38(7):549-53. PubMed ID: 9738258
[TBL] [Abstract][Full Text] [Related]
19. Cerebral venous thrombosis in adult patients with acute lymphoblastic leukemia or lymphoblastic lymphoma during induction chemotherapy with l-asparaginase: The GRAALL experience.
Couturier MA; Huguet F; Chevallier P; Suarez F; Thomas X; Escoffre-Barbe M; Cacheux V; Pignon JM; Bonmati C; Sanhes L; Bories P; Daguindau E; Dorvaux V; Reman O; Frayfer J; Orvain C; Lhéritier V; Ifrah N; Dombret H; Hunault-Berger M; Tanguy-Schmidt A
Am J Hematol; 2015 Nov; 90(11):986-91. PubMed ID: 26214580
[TBL] [Abstract][Full Text] [Related]
20. Management of thrombotic complications in acute lymphoblastic leukemia.
Zia AN; Chitlur M
Indian J Pediatr; 2013 Oct; 80(10):853-62. PubMed ID: 23912824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
